Cape Heart Technologies has invented and a one of a kind hand-held Atril Fib detection device. This device and its arrhythmia sensing technology can be incorporated into an iPhone.
Upon market release, this device will be readily available OVER THE COUNTER and will provide people with a real-time heart rhythm screening tool to detect irregular heart rhythms.
Cape Heart Technologies, LLC was founded by Edward Bischoff and Gary Menszer, MD and is the exclusive owner of the Cardiac Rhythm Monitoring Device. On March 6, 2007, the CRMD received U.S. Patent # 7,187,965. Two additional patents were granted in 2009.
Our marketing study indicates we have a $2.5 Billion dollar worldwide market, specifically to patients diagnosed with Atrial Fibrillation. Additional potential markets include fitness, healthcare, and pharmaceutical compliance by allowing the device user to be proactive with his medical treatment.